Cartesian Therapeutics Overview

Cartesian Therapeutics Operating Income

Operating Income for RNAC.

Quarterly Operating Income

$-26499000.00

↑ 21.06% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-70249000.00

↓ 11.35% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric

Total Revenue Cost of Revenue Gross Profit Research & Development Selling, General & Admin Operating Income Other Income Expense Net EBIT Income Tax Net Income Profit Margin